Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Immunotherapy is the newest approach to combat cancer. It can be achieved using several strategies, among which is the dendritic cell (DC) vaccine therapy. Several clinical trials are ongoing using DC vaccine therapy either as a sole agent or in combination with other interventions to tackle differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadeldin, Mona Kamal, Abdel-Aziz, Amal Kamal, Abdellatif, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836805/
https://www.ncbi.nlm.nih.gov/pubmed/33221134
http://dx.doi.org/10.1016/j.mehy.2020.110365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836805/
https://www.ncbi.nlm.nih.gov/pubmed/33221134
http://dx.doi.org/10.1016/j.mehy.2020.110365

Ejemplares similares